Skip to content

aluetta 6mg

by Ares Trading SA Switzerland EUDAMED

Ref U122221BModel aluetta

EMDN A99

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number4054839aluettaHJ Basic UDI-DIDate10 May 2022RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Not covered

European Union — CE/MDR Active

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 22 Oct 2026

Device Name
aluetta
Model / Reference
aluetta, U122221B
Primary DI / UDI-DI
04065266536935
Basic UDI-DI
4054839aluettaHJ
EMDN Code
A99 Devices for administration, withdrawal and collection - other
Device Class
Class I
Market of Registration
Germany

Manufacturer details

EUDAMED SRN
CH-MF-000021799
Authorised representative
Merck Healthcare KGaA DE-AR-000007181

Other devices from Ares Trading SA

See all devices from Ares Trading SA →

Properties & raw data

Show properties, registry sources and raw records
  • Administering Medicine
  • Measuring Function
Other properties (11)
  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 605843e3-fd8e-478c-ad33-8d08f2bcde92 61 fields · synced 22 Oct 2026